Featuring an interview with Dr Lajos Pusztai. Published March 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
AMA PRA Category 1 Credit™Up to 0.75 credits
MOC types
ABS — Accredited CMEUp to 0.75 pointsABIM — Medical KnowledgeUp to 0.75 pointsABS — Self-AssessmentUp to 0.75 points
FDA REMS
No
Qualifies for MIPS
No
Target Specialties
Pricing
100% of listed courses are free
240 of 240 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- Credit · Up to 0.75 credits
- MOC · Up to 0.75 points
-
ReleasedMar 18, 2026
-
Last day to claim creditMar 20, 2027 5 months left
-
Research to Practice 5-Minute Journal Club: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays in the Treatment of Breast Cancer | 2026 (Audio Program)
-
Research to Practice 5-Minute Journal Club: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays in the Treatment of Lung Cancer | 2026 (Video Program)
-
Research to Practice 5-Minute Journal Club: Current and Future Role of Tumor-Informed Circulating Tumor DNA Assays in the Treatment of Genitourinary Cancers Issue 1 | 2026 (Video Program)
-
Learner’s Digest International (TM) Using ctDNA to Drive Decision Making in Adjuvant Chemotherapy for Colon Cancer
-
PRIME Education, Inc. (PRIME®) Real-Time Circulating ctDNA Monitoring for ESR1 Mutations in ER+ Breast Cancer
-
Physicians’ Education Resource Cases and Conversations: Translating ctDNA Into Clinical Decisions in Breast Cancer
